Originally appeared on Adweek
The advertising industry is experiencing a significant shift resulting from Oracle’s market exit. Over the years, Oracle’s advertising tools—built through key acquisitions like Crosswise, BlueKai, Datalogix, and Grapeshot—have become essential for many marketers, data providers, and platforms. With Oracle’s departure, stakeholders are left searching for reliable alternatives to maintain their data-driven strategies.
While this transition may seem daunting, it presents a unique opportunity to reassess audience and identity solutions. With the growing importance of adaptability and interoperability, now is the perfect time for advertisers, agencies, publishers, and platforms to adopt future-focused strategies.
Oracle’s legacy: A combination of acquisitions
Oracle’s advertising business wasn’t a unified solution but a collection of acquired technologies. Crosswise provided a cross-device identity graph; BlueKai offered a robust data management platform (DMP); Datalogix specialized in offline purchase data; and Grapeshot was known for its contextual targeting. Together, these tools powered a comprehensive offering for advertisers, data providers, and platforms.
Yet, much of Oracle’s advertising success stemmed from the external data it used. For example, many of Oracle’s automotive audiences relied heavily on third-party data, largely powered by Experian data. This means that while Oracle may no longer be an option, many of the services marketers depended on through Oracle are still available from Experian, ensuring continuity.
What this means for advertisers and agencies
For advertisers and agencies, Oracle’s exit means losing access to its syndicated audiences. Fortunately, this doesn’t have to cause a major disruption. As one of Oracle’s primary data providers, we’ve mapped Oracle’s audiences to our own, ensuring marketers can easily maintain their targeting strategies without losing performance or efficiency.
With access to over 2,400 syndicated audiences across key verticals such as demographics, automotive, retail purchases, or financial data, advertisers can continue their campaigns with confidence and precision.
What sets us apart? Powered by data ranked #1 in accuracy by Truthset, our audiences are built on reliable, offline, deterministic data — like name, address, phone number, and email. This means advertisers can be confident that they are reaching the right audiences across all channels. With our audiences available across 30+ ad platforms, including programmatic, TV, and social media, advertisers and agencies have easy access to keep their campaigns running.
For advertisers that ran audience targeting using Grapeshot’s Contextual Platform, our new Contextually-Indexed Audiences are a replacement built for the evolving digital media landscape. By combining the precision of audience targeting with the flexibility of contextual targeting, marketers get a privacy-safe, yet scalable way to target audiences that is not reliant on cookies or other user identifiers. Marketers can activate these audiences through leading demand-side platforms (DSPs) or through Audigent private marketplaces (PMPs).
A new opportunity for data providers
Oracle’s marketplace has long been a crucial distribution channel for third-party data providers, particularly through BlueKai. With its closure, providers have an opportunity to explore new onboarding services and marketplaces that offer similar or even better reach and effectiveness.
New alternative onboarding solutions are emerging, particularly in areas like TV and digital, ensuring that the loss of Oracle’s services does not leave a significant gap. These solutions are being built to overcome the challenges typically present with data onboarding — complicated integration processes, limited ID matching capabilities, and opaque pricing structures. One such solution is Experian’s new Third-Party Onboarding.
What sets us apart? With our digital and offline identity capabilities embedded within this solution, data providers receive superior programmatic and connected TV (CTV) reach and addressability compared to the competition. The first data providers – Adentro, Kontext, L2, and Webbula – are already using this solution to increase the adoption of their audiences and maximize their revenue.
Additionally, new marketplaces are emerging that aim to fill the void left by Oracle, offering distribution to key destinations and providing data providers with continued access to advertisers who require high-quality, third-party data.
Platforms shift to new audience solutions
Platforms that relied on Oracle for third-party data and audience onboarding are now facing challenges in maintaining their ability to target specific audiences. This could affect their inventory’s attractiveness to buyers. However, we offer a seamless solution for platforms looking to replace Oracle’s capabilities.
As one of Oracle’s primary data providers, we’ve already mapped Oracle’s audiences to our catalog of over 2,400 syndicated audiences. Platforms can continue providing precise audience targeting and ensure advertisers receive the performance that they demand.
Additionally, Third-Party Onboarding builds upon the investment and infrastructure used to distribute our own audience segments, providing platforms with audiences from leading third-party data providers.
Moving forward: Embracing connectivity
We’re dedicated to powering data-driven advertising through connectivity. With best-in-class syndicated audiences, new Contextually-Indexed Audiences, and an easy-to-use Third-Party Onboarding solution, we’re enabling advertisers, agencies, data providers, and ad platforms to improve their marketing operations.
Oracle’s departure marks the end of one era, but it also opens the door to a future where collaboration, interoperability, and connectivity define the landscape. By choosing partners like us, advertisers, agencies, and platforms can ensure they remain agile, innovative, and well-equipped to thrive in this new era of data-driven marketing.
Reach out to your account representative or our audience team for information about our comprehensive audience mapping and finding the right audiences for your campaigns.
Download our audience lookbook to discover more about Experian’s audiences.
Latest posts
Privacy-forward pharma media supports more informed healthcare journeys Effective pharma marketing depends on reaching patients, caregivers, and healthcare professionals (HCPs) with useful information in appropriate, privacy-forward ways. The goal is to make relevant education easier to find, support more informed conversations, and help brands understand how media contributes across the health journey. In this Ask the Expert session, Natalie Mancuso, SVP, Data Partnerships at DeepIntent, joins Sheila Wirick, who leads the health team at Experian, to discuss how to craft patient and HCP campaigns, privacy-safe activation workflows, connected TV (CTV), and measurement approaches built for pharma. Why should your media plan start with understanding the patient and provider The patient-and-provider journey should inform your media plan, as treatment decisions in pharma are increasingly informed, personal, and patient-driven. With more health information available than ever, patients are playing a more active role in understanding their options and participating in treatment conversations. As other industries become more customer-centric, pharma media planning needs to become more patient-centric. “We’ve got patients who are more informed, more involved in their treatment decisions than ever. The accessibility of data and information and the ways we can consume it with just AI alone is so vast that if we’re not arming people with the right information in real time, we’re missing the boat.”Natalie Mancuso, SVP, Data Partnerships This means media should be aligned to where a patient or provider is in the decision journey and what they need at that moment. Early on, media may play an educational role by building awareness of a condition, symptom, or treatment category. Later, it may help support more specific questions, treatment consideration, access, affordability, or adherence. The patient-provider conversation remains the key boundary. That exchange should stay private and clinically led. Media can play a valuable role before and after those moments by offering information that helps patients and providers feel more informed. How can brands connect patient and HCP messaging responsibly? It’s critical for agencies and brands to deliver relevant messaging to inform each stakeholder’s needs throughout the treatment journey, especially ahead of key clinical milestones. To execute this, brands must exercise privacy-forward activation, keeping patient and HCP identity, activation, and measurement paths separate, while using a common workflow layer to support the same brand goal. Experian helps pharma marketers do this by acting as an independent, privacy-forward identity, data, and workflow layer. We bring together high-fidelity matching, governed onboarding, and non-clinical consumer context, so patient and HCP engagement can be activated more accurately across channels and connected to reporting. The distinction is not only where each audience is reached. HCPs may be engaged in both professional and personal environments, but their needs are different from patients’. For example, an HCP may receive messaging about co-pay savings for eligible patients, while a patient may receive information about patient support programs. These are different messages for different audiences, but they ladder up to the same goal: informing both parties in a privacy-forward, relevant way. Hear from Natalie Mancuso in our 2026 State of advertising report In our 2026 State of advertising report, Natalie shares why identity serves as the connective infrastructure that links planning, activation, and measurement across connected TV (CTV), programmatic, commerce media, and walled garden environments. Download the report Watch Natalie’s Q&A What does privacy-forward activation look like in pharma? Pharma brands often start with fragmented patient and HCP signals. Privacy-forward activation turns those inputs into usable audiences by first confirming that the data can be used, then translating identity in controlled environments that protect personally identifiable information through tokenization or other methodologies. For DTC, that means building and matching audiences without relying on inferred health conditions from browsing behavior. For HCPs, it means connecting professional identity to verified sources in a way that supports activation and measurement. In a category shaped by HIPAA, state privacy laws, internal review, and consumer sensitivity, building privacy in from sourcing through activation is what makes responsible health media possible. How can CTV play a more useful role in pharma? CTV can play a more useful role in healthcare when it’s connected to a larger, privacy-forward plan and not treated as just an awareness channel. DeepIntent connects CTV and digital exposure data using identity signals, such as National Provider Identifiers (NPIs), hashed email addresses, IP addresses, device IDs, and household signals, where permitted and reviewed. That identity layer helps support sequencing and suppression across streaming, endemic, mobile, and digital settings. In practice, CTV can introduce targeted education or broad brand awareness, and later touchpoints can provide sequential information in the right channels. Instead of repeating the same message, brands can make pivots based on engagement and context. “For us, it starts with identity and not panels. When we’re resolving CTV and digital exposures to the same person, we’re leveraging signals so that every touchpoint across streaming, endemic, and mobile is recognized as the same individual, not model lookalikes.”Natalie Mancuso, SVP, Data Partnerships For pharma, campaign performance should not be measured by reach alone. A stronger approach looks at whether sequenced engagement contributes to meaningful downstream signals, including: Prescription activity Provider engagement Referral patterns Patient compliance Adherence signals, where measurement is permitted Why should messaging and reporting change in pharma? Pharma campaigns are journeys with changing information needs. Reporting should guide the campaign optimization. “If I’m launching into a market with a new class of drug, I’m asking what education needs to be put into the market – from both an HCP and a consumer standpoint – to build awareness?”Natalie Mancuso, SVP, Data Partnerships Clicks and website visits still have a place, but they can’t tell the full pharma story. DeepIntent processes data in real time, giving brands an up-to-date read on how media connects to campaign engagement. Campaign signals can help teams optimize audience logic, creative, channel mix, or sequencing during a live campaign. Heading Test for Media & Text Block Content Test for Media &Text Block Learn more Heading Test for Media & Text Block Content Test for Media &Text Block Learn more Heading Test for Media & Text Block Content Test for Media &Text Block Learn more Explore how privacy-safe pharma activation can make an impact Experian brings marketing data and identity expertise for health marketing and DeepIntent adds pharma-specific activation experience. Together, we help brands connect patient and HCP strategies responsibly, with privacy built in from the start. Watch the full video with our experts to hear Sheila Wirick and Natalie Mancuso discuss patient and HCP messaging, CTV, privacy-safe activation, and outcome measurement for pharma brands. About our experts Natalie Mancuso SVP, Data Partnerships, DeepIntent Natalie Mancuso is SVP, Data Partnerships at DeepIntent and a leader in health-focused AdTech and DSP strategy. With over 20 years of experience growing billion-dollar healthcare brands, she turns complex data into scalable, performance-driven solutions that keep marketers ahead of industry change. Sheila Wirick Director of Health Sales, Experian Sheila Wirick is the Director of Health Sales at Experian with more than 20 years of experience in data and analytics. As Director of Health Sales at Experian Marketing Services, she collaborates with healthcare, pharmaceutical, and nonprofit organizations to apply data and insights that enhance customer retention, brand awareness, and acquisition. She is committed to helping organizations use data to deliver measurable results and meaningful impact. FAQs What makes a pharma audience activation-ready? A pharma audience is activation-ready when patient or HCP inputs can be translated into usable audiences with the right accuracy, controls, interoperability, and destination readiness. For patient engagement, that may include privacy-safe cohort construction, caregiver logic, non-clinical enrichment and appropriate exclusion rules. For HCP engagement, it may include governed identity inputs such as NPI, specialty, practice location, professional address and other verified attributes where appropriate. How can pharma brands sequence messages across channels responsibly? Pharma brands can sequence messages responsibly by giving each channel a clear role and using audience logic to maintain continuity. CTV and out-of-home can support awareness, social can reinforce the message, search can capture active research and point-of-care or rep-triggered channels can support decision moments. The workflow should preserve separation between patient and HCP identity strategies. What should pharma marketers measure beyond clicks and site visits? Pharma marketers should measure whether media connects to outcomes such as audience quality, prescription activity, qualified HCP engagement, verified delivery, referral patterns, therapy starts or adherence signals where permitted. These outcomes often depend on partner-enabled workflows, clean rooms, and aggregated outputs rather than direct end-to-end tracking. How does Experian help pharma brands connect identity, activation and measurement? Experian acts as an independent privacy-first identity, data, and workflow layer for pharma marketers. We help brands bring together identity, high-fidelity matching, governed onboarding, non-clinical consumer context, and partner interoperability so patient and HCP engagement can be activated more accurately across channels and connected more cleanly to partner-enabled measurement. Latest posts
Heading This is my content Heading This is my content Title sdf sdf sdf sdf sdf sdf sdf
Use case #1: Identifying customer spending potential to boost growth for a retail chain Objective Solution Results The solution By syncing its cookies with the Digital Graph, the DSP gained access to related identifiers, including: This expanded identity universe gave the DSP a unified view of individuals and households, making it possible to connect impressions to conversions across devices and channels. With each weekly refresh, attribution models stayed accurate and up to date, turning fragmented signals into proof of performance. Results Within weeks, the DSP saw measurable improvements